Insulin Delivery Devices Market Share, Growth | Forecast 2025

report image

Insulin Delivery Devices Market to 2025 - Global Analysis and Forecasts By Product (Insulin Pens, Insulin Pumps, Insulin Syringes, Pen Needles, and Others), End User (Patients/Homecare and Hospitals & Clinics), and Geography

Publication Month: Oct 2018 | Report Code: TIPHE100000819 | No. of Pages: No. of Pages194 | Category: Medical Device | Status: Published

The insulin delivery devices market accounted to US$ 11,869.0 Mn in 2017 and is expected to grow at a CAGR of 8.7% during the forecast period 2018 – 2025, to account to US$ 22,830.0 Mn by 2025.

North America is the largest geographic insulin delivery devices market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as, rising geriatric population and increasing prevalence of diabetes in the region.

Lucrative Regional Markets

Get more information on this report :

Market Insights

Rapid Growth in the Geriatric Population

Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the globe. These population is growing exponentially worldwide. According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050.

Increasing Technological Advancement in Insulin Delivery Devices

The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices. For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. In addition, in July 2018, Abbott announced to have a FDA approval for the FreeStyle Libre 14 day Flash Glucose Monitoring system that allows people with diabetes to wear the sensor up to 14 days with high accuracy. These advancements are expected to offer increasing demand for the products, hence providing better share to the market players.

Product Insights

The global insulin delivery devices market by product was led by insulin pens segment. In 2017, the insulin pens segment held a largest market share of 31.3% of the insulin delivery devices market, by product. The segment is also expected to dominate the market in 2025, since they offer increasing ease of use; increasing patient satisfaction and adherence; accuracy for delivering small doses of insulin.

End User Insights

The insulin delivery devices market by end user was segmented into patients/homecare and hospitals & clinics. The patients/homecare segment held the largest share of the market, by end user. The segment is also likely to dominate during the forecast period, as it allows a patient to regulate as well as monitor the glucose levels as well as administer insulin at home.

Insulin delivery devices Market, by End User

Get more information on this report :

Strategic Insights

Report Coverage - Insulin Delivery Devices Market
Report CoverageDetails
Market Size Value inUS$ 11,869.0 Million in 2017
Market Size Value byUS$ 22,830.0 Million by 2025
Growth rateCAGR of 8.7% from 2018-2025
Forecast Period2018-2025
Base Year2018
No. of Pages194
No. of Tables103
No. of Charts & Figures60
Historical data availableYes
Segments coveredProduct , End User , and Geography
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product approvals and agreements were observed as the most adopted strategy in global insulin delivery devices industry. Few of the product approvals and agreements made by the players in the market are listed below;

2018:In June, 2018, Medtronic received CE Mark for its MiniMed(TM) 670G Hybrid Closed Loop System.
2018:In February, 2018, Tandemand Rubin Medical signed an agreement for distribution of insulin pumps in Scandinavia.


By Product

  • Insulin Pens
  • Reusable Insulin Pens
  • Disposable Insulin Pens
  • Insulin Pumps
  • Tube Pumps
  • Patch Pumps
  • Insulin Syringes
  • Pen Needles
  • Standard Pen Needles
  • Safety Pen Needles
  • Others

By End User

  • Patients/Homecare
  • Hospitals & Clinics

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • UK
  • Asia Pacific (APAC)

    • China
    • India
    • Japan
  • Middle East & Africa (MEA)

    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)

    • Brazil

Company Profiles

  • BD
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Insulet Corporation
  • Medtronic
  • Tandem Diabetes Care, Inc.
  • Eli Lilly and Company
  • Biocon
  • Owen Mumford, Ltd.
  • Sanofi

The List of Companies - Insulin Delivery Devices Market

  1. BD
  2. Novo Nordisk A/S
  3. B. Braun Melsungen AG
  4. Insulet Corporation
  5. Medtronic
  6. Tandem Diabetes Care, Inc.
  7. Eli Lilly and Company
  8. Biocon
  9. Owen Mumford, Ltd.
  10. Sanofi
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the insulin delivery devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global insulin delivery devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550 $3000
  • $6550 $4000
  • $8550 $5000

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount